Clinical Trial Update: Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update for intravesical LP08 in interstitial cystitis/painful bladder syndrome has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis
• Painful Bladder Syndrome

Drugs mentioned

• LP08

Snippet

Sponsor: Lipella Pharmaceuticals, Inc. | Conditions: Interstitial Cystitis | Phase 2 | Status: COMPLETED